To include your compound in the COVID-19 Resource Center, submit it here.

Mirati raises $80M in follow-on

Mirati Therapeutics Inc. (NASDAQ:MRTX) raised $80 million through the sale of 2 million shares and 4.1 million pre-funded

Read the full 184 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE